Adient (NYSE:ADNT – Get Free Report) had its price target dropped by analysts at UBS Group from $20.00 to $13.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s price objective would indicate a potential upside of 24.94% from the company’s current price.
A number of other research firms have also recently commented on ADNT. Wells Fargo & Company cut shares of Adient from an “overweight” rating to an “equal weight” rating and dropped their price target for the stock from $27.00 to $20.00 in a research note on Monday, December 16th. Bank of America cut Adient from a “neutral” rating to an “underperform” rating and cut their target price for the company from $24.00 to $18.00 in a research note on Tuesday, March 4th. StockNews.com raised Adient from a “hold” rating to a “buy” rating in a research note on Tuesday, April 1st. Barclays dropped their price objective on Adient from $24.00 to $21.00 and set an “equal weight” rating for the company in a report on Wednesday, January 22nd. Finally, JPMorgan Chase & Co. reduced their target price on Adient from $24.00 to $21.00 and set a “neutral” rating on the stock in a research note on Monday, January 27th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $20.00.
Read Our Latest Report on ADNT
Adient Trading Down 1.7 %
Adient (NYSE:ADNT – Get Free Report) last posted its earnings results on Tuesday, January 28th. The company reported $0.27 earnings per share for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.05). Adient had a positive return on equity of 6.94% and a negative net margin of 0.01%. During the same quarter in the prior year, the company earned $0.31 earnings per share. Sell-side analysts expect that Adient will post 1.76 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Adient
Several hedge funds have recently modified their holdings of the business. Covestor Ltd grew its stake in Adient by 10.6% in the fourth quarter. Covestor Ltd now owns 6,062 shares of the company’s stock valued at $104,000 after purchasing an additional 580 shares during the last quarter. Mariner LLC lifted its position in Adient by 8.6% during the 4th quarter. Mariner LLC now owns 10,157 shares of the company’s stock worth $175,000 after acquiring an additional 801 shares during the period. Point72 Hong Kong Ltd purchased a new stake in Adient during the 4th quarter valued at about $25,000. Oarsman Capital Inc. increased its holdings in shares of Adient by 98.7% in the fourth quarter. Oarsman Capital Inc. now owns 2,966 shares of the company’s stock valued at $51,000 after purchasing an additional 1,473 shares during the period. Finally, R Squared Ltd acquired a new position in shares of Adient in the fourth quarter valued at about $32,000. Hedge funds and other institutional investors own 92.44% of the company’s stock.
Adient Company Profile
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
Featured Stories
- Five stocks we like better than Adient
- How to Read Stock Charts for Beginners
- JPMorgan is a Buy, if You Can Handle The Volatility
- What is Short Interest? How to Use It
- United States Steel’s Crash: An Unmissable Buying Opportunity
- Insider Trading – What You Need to Know
- Rocket Lab Stock: Weathering the Storm, Time for a Comeback?
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.